type here...

CATEGORIES

AI Chat GPT GenAI

LATEST

123...10Page 2 of 10

TRENDING

EDITORS CHOICE

A Digital Turning Point in Migraine Care: CT-132 FDA Approval to Market is a Win for Patients and Proof that Clinical Evidence Matters

Gil Bashe, Medika Life Editor -
First Digital Health App United States Approval for Migraine Treatment with a Comprehensive Indication of Use

Soup.

John Nosta -
Today's chaotic stew of code, chaos and creation.

Medicaid at a Crossroads: Safe AI, Shifting Policy and the Stakes for People’s Health

Gil Bashe, Medika Life Editor -
Medicaid is one of America’s most complex and essential Federal health programs, serving more than 70 million people. Its design, Federal standards, and state-level...

Science Has No Borders – And Neither Should Human Potential

Gil Bashe, Medika Life Editor -
Here at the HIMSS AI in Healthcare Forum, held in Brooklyn—long a gateway for immigration and innovation—the gathering has become more than just a...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories